drug · small molecule
patient view →rucaparib camsylate
Marketedupdated 2mo agoby pharmaand GmbH🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 1 investigational indication.
targets
PARP 1, 2 and 3
all catalysts(9)
approval · 9
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that